@article{ref1,
title="Suicidal ideation among people with Parkinson's disease and comparison with a control group",
journal="International journal of geriatric psychiatry",
year="2023",
author="Santos-García, Diego and de Deus Fonticoba, Teresa and Cores Bartolomé, Carlos and Feal Panceiras, Maria J. and García Díaz, Iago and Íñiguez Alvarado, Maria Cristina and Jesús, Silvia and Boungiorno, Maria Teresa and Planellas, Lluís and Cosgaya, Marina and García Caldentey, Juan and Caballol, Nuria and Legarda, Ines and Hernández Vara, Jorge and Cabo, Iria and López Manzanares, Lydia and González Aramburu, Isabel and Ávila Rivera, Maria A. and Gómez Mayordomo, Víctor and Nogueira, Víctor and Puente, Víctor and Dotor García-Soto, Julio and Borrué, Carmen and Vila, Berta Solano and Álvarez Sauco, María and Vela, Lydia and Escalante, Sonia and Cubo, Esther and Carrillo Padilla, Francisco and Martínez Castrillo, Juan C. and Sánchez Alonso, Pilar and Alonso Losada, Maria G. and López Ariztegui, Nuria and Gastón, Itziar and Kulisevsky, Jaime and Blázquez Estrada, Marta and Seijo, Manuel and Rúiz Martínez, Javier and Valero, Caridad and Kurtis, Mónica and de Fábregues, Oriol and González Ardura, Jessica and Alonso Redondo, Ruben and Ordás, Carlos and López Díaz, Luis M. and McAfee, Darrian and Martinez-Martin, Pablo and Mir, Pablo",
volume="38",
number="5",
pages="e5919-e5919",
abstract="BACKGROUND: Detection of suicidal ideation (SI) is key for trying to prevent suicide. The aim of this study was to analyze the frequency of SI and related factors in Spanish people with Parkinson's Disease (PwPD) and to compare them with a control group. <br><br>METHODS: PD patients and controls recruited from the Spanish cohort COPPADIS from January 2016 to November 2017 were included. Two visits were conducted: V0 (baseline); V2 (2-year ± 1 month follow-up). SI was defined as a score ≥1 on item nine of the Beck Depression Inventory-II (BDI-II). Regression analyses were conducted to identify factors related to SI. <br><br>RESULTS: At baseline, 693 PwPD (60.2% males; 62.59 ± 8.91 years old) and 207 controls (49.8% males; 60.99 ± 8.32 years old) were included. No differences between PwPD and controls were detected in SI frequency at either V0 (5.1% [35/693] vs. 4.3% [9/207]; p = 0.421) or at V2 (5.1% [26/508] vs. 4.8% [6/125]; p = 0.549). Major depression (MD) and a worse quality of life were associated with SI at both visits in PwPD: V0 (MD, OR = 5.63; p = 0.003; PDQ-39, OR = 1.06; p = 0.021); V2 (MD, OR = 4.75; p = 0.027; EUROHIS-QOL8, OR = 0.22; p = 0.006). A greater increase in the BDI-II total score from V0 to V2 was the only factor predicting SI at V2 (OR = 1.21; p = 0.002) along with an increase in the total number of non-antiparkinsonian drugs (OR = 1.39; p = 0.041). <br><br>CONCLUSION: The frequency of SI (5%) in PwPD was similar to in controls. Depression, a worse quality of life, and a greater comorbidity were related to SI.<p /> <p>Language: en</p>",
language="en",
issn="0885-6230",
doi="10.1002/gps.5919",
url="http://dx.doi.org/10.1002/gps.5919"
}